IBI318 Plus Lenvatinib Tackles Resistant Lung Cancer
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
(Barcelona, Spain — September 9, 2025) — At the forefront of oncological research, a groundbreaking study revealed at the International ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine